Bank of New York Mellon Corp - ADMA BIOLOGICS INC ownership

ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 98 filers reported holding ADMA BIOLOGICS INC in Q4 2020. The put-call ratio across all filers is 2.13 and the average weighting 0.0%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of ADMA BIOLOGICS INC
ValueSharesWeighting
Q3 2023$2,884,405
-0.9%
805,700
+2.1%
0.00%0.0%
Q2 2023$2,911,958
+30.2%
789,149
+16.8%
0.00%
Q1 2023$2,236,923
-11.0%
675,808
+4.3%
0.00%
-100.0%
Q4 2022$2,513,773
+78.0%
647,880
+11.5%
0.00%
Q3 2022$1,412,000
+42.6%
580,827
+16.2%
0.00%
Q2 2022$990,000
+547.1%
499,810
+499.3%
0.00%
Q1 2022$153,000
+135.4%
83,401
+79.6%
0.00%
Q4 2021$65,000
+25.0%
46,4340.0%0.00%
Q3 2021$52,000
-45.8%
46,434
-22.3%
0.00%
Q2 2021$96,000
-73.5%
59,750
-70.9%
0.00%
Q1 2021$362,000
-10.8%
205,412
-1.6%
0.00%
Q4 2020$406,000
-12.3%
208,775
+7.7%
0.00%
Q3 2020$463,000
-27.1%
193,822
-10.6%
0.00%
Q2 2020$635,000
+13.8%
216,837
+12.0%
0.00%
Q1 2020$558,000
-13.8%
193,654
+19.8%
0.00%
Q4 2019$647,000
+8.7%
161,653
+20.9%
0.00%
Q3 2019$595,000
+87.7%
133,752
+62.8%
0.00%
Q2 2019$317,000
+37.8%
82,176
+35.5%
0.00%
Q1 2019$230,000
+75.6%
60,631
+10.6%
0.00%
Q4 2018$131,000
-61.5%
54,8280.0%0.00%
Q3 2018$340,000
+37.7%
54,8280.0%0.00%
Q2 2018$247,000
+183.9%
54,828
+188.0%
0.00%
Q1 2018$87,000
+31.8%
19,037
-10.8%
0.00%
Q3 2017$66,000
-16.5%
21,3440.0%0.00%
Q2 2017$79,00021,3440.00%
Other shareholders
ADMA BIOLOGICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Velan Capital Investment Management LP 4,000,000$13,240,00011.29%
Stonepine Capital Management, LLC 7,661,690$25,360,1948.50%
Altium Capital Management LP 2,870,000$9,499,7005.27%
Caligan Partners LP 1,662,613$5,503,2493.84%
AWM Investment Company, Inc. 6,015,000$19,909,6502.69%
Perceptive Advisors 11,900,255$39,389,8441.16%
EAM Investors, LLC 1,035,752$3,428,3390.67%
OBERWEIS ASSET MANAGEMENT INC/ 1,169,500$3,871,0450.60%
Magnetar Financial LLC 7,074,722$23,417,3300.46%
Virtus ETF Advisers LLC 83,925$277,7920.15%
View complete list of ADMA BIOLOGICS INC shareholders